Researchers has significantly boosted the development of the novel therapy for amyloid heart disease, employing Attruby. Early clinical results reveals promising improvements for patients suffering with the serious condition. The focus highlights BridgeBio's focus to addressing unmet medical demands in this heart disease arena. Attruby: BridgeBio'